Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression
Status:
Withdrawn
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
The effectiveness of glabellar injection of botulinum toxin type A (BTA) in treating
depression has not yet been investigated in elderly patients. The study aims in addressing
the question if glabellar injection of BTA is effective in treating geriatric depression.
Phase:
Phase 1
Details
Lead Sponsor:
Helse Stavanger HF
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A onabotulinumtoxinA